Why Ozempic Works for Some People and Not Others — New Research Points to How You Eat
The Short Version
- A 12-month Japanese study found that external eaters — people triggered to overeat by food cues in their environment — show continuously improving results on GLP-1 drugs like Ozempic, while emotional eaters do not follow the same trajectory over the same period.
- GLP-1 medications act on the brain's external eating pathway; they don't address the psychological mechanisms driving emotional eating, which is why eating behavior type predicts treatment outcomes more reliably than metabolism or effort.
- About 10% of people don't respond to Ozempic-type drugs at all, and eating behavior pattern likely explains part of the wider variation in individual results — a conversation worth having with your doctor before or after starting treatment.
- For emotional eaters, CBT and mindfulness-based eating programs show 40–60% reductions in emotional eating episodes in published trials — the researchers' recommendation is to add this support alongside medication, not instead of it.
- Knowing your dominant eating pattern is useful without medication too — external eaters can work with environmental design, while emotional eaters are pointed toward stress regulation practices, including the act of cooking itself.
By now, you've probably encountered this pattern at least once. Someone you know started on Ozempic or a similar GLP-1 drug and lost weight steadily for months — noticeably, convincingly. Someone else started the same medication at the same dose and stalled out by month three, wondering what they're doing wrong. The standard responses — "metabolism varies," "give it more time," "some people just respond differently" — don't provide much to work with. A new 12-month study from researchers at Gifu University and Kyoto University in Japan offers a much cleaner answer to why Ozempic works for some people and not others: it comes down to what triggers your eating, not what you eat.
The Study That Explains Why Ozempic Works for Some People and Not Others
The Study That Explains Why Ozempic Works for Some People and Not Others
Researchers in Gifu Prefecture, Japan observed 92 people with type 2 diabetes taking GLP-1 receptor agonists — the medication class that includes semaglutide (sold as Ozempic for diabetes, Wegovy for weight management) — for a full 12 months. Measurements were taken at baseline, at three months, and at twelve months, tracking not just weight but fat mass, muscle mass, and eating behavior type.
Using validated behavioral assessments, the team classified each participant into one of three eating patterns. External eaters overeat in response to environmental food cues — the sight of food, its smell, social settings, advertising. Emotional eaters reach for food in response to internal states — stress, sadness, anxiety, boredom. Restrained eaters cycle between careful dietary control and episodes of eating past fullness, often in a restriction-and-lapse pattern.
The finding was direct: external eaters showed continuously improving weight and fat reductions across the full 12-month period, with participants who had the highest external eating scores at baseline experiencing the greatest overall improvements by month 12. Emotional eaters did not follow the same trajectory. The same drug, the same period, meaningfully different outcomes — and the difference came from the mechanism, not the effort.
One finding worth naming clearly: muscle mass remained stable across all participants throughout the year. Concerns about GLP-1 medications causing muscle loss are worth raising with your doctor, but this study did not support that pattern.
For context, here is how semaglutide performed across the general population in the large-scale STEP-1 clinical trial, published in the New England Journal of Medicine:
Those are strong headline numbers. But they average across all participants, including people whose eating pattern is a poor match for the drug's mechanism. The Japanese study points to where those averages begin to diverge.
External Eating vs. Emotional Eating — What's the Actual Difference?
External Eating vs. Emotional Eating — What's the Actual Difference?
From the outside, both patterns look the same: eating past physical hunger. The internal mechanism is different in ways that matter a great deal for treatment.
External eating is triggered by the environment. You walk through a food court when you're not hungry and find yourself wanting something anyway. You're at a social gathering and keep returning to the food table — not from hunger but because the food is present, visible, and people around you are eating. You see a food advertisement and notice a pull toward the kitchen. The prompt comes from outside — sensory, situational, social.
Emotional eating is triggered by internal state. Stress reaches a threshold and something moves toward food. A hard day ends and the kitchen offers relief. Loneliness, anxiety, boredom — these become cues that point toward eating as regulation or comfort. The need the food is meeting is real; the question is whether food is the most useful way to meet it.
GLP-1 drugs work primarily on the external eating pathway. These medications act on receptors in the hypothalamus and the brain's reward circuitry to reduce appetite and dampen the response to environmental food cues. As Prof. Daisuke Yabe of Kyoto University stated directly, GLP-1 receptor agonists are most effective for "individuals who experience weight gain due to overeating triggered by external stimuli."
The emotional eating pathway operates differently. When food is meeting a psychological need — regulation, relief, distraction from discomfort — reducing appetite signaling doesn't necessarily interrupt that drive. The need hasn't changed; only the tool available to meet it. This isn't a design flaw in the medication. It's a useful signal that emotional eating requires a tool designed for the psychological mechanism.
Research using the Dutch Eating Behavior Questionnaire (DEBQ), one of the most widely validated instruments for characterizing eating patterns in clinical and community populations, shows how these patterns are distributed among adults in weight management research:
Most people aren't exclusively one type. DEBQ research consistently shows external eating as the most common dominant pattern, but overlaps are real and common. What matters for predicting GLP-1 response isn't perfect categorization — it's honest recognition of which pattern does most of the driving.
How to Recognize Your Own Pattern
How to Recognize Your Own Pattern
The simplest starting point is context: when you eat past fullness, or when you reach for food without physical hunger — where are you, and what was happening just before?
If it happens most often in social settings, restaurants, while cooking and smelling what's on the stove, at gatherings, or simply when food is present and visible — that's the external pattern at work. The environment is doing the prompting.
If it happens most often when you're alone, at the end of a hard day, when an uncomfortable emotion is present, or when you're looking for something to do and food becomes the answer — that's the emotional pattern. The internal state is doing the prompting.
Restrained eating tends to show up as a cycle: periods of careful, deliberate control followed by eating that feels out of proportion to the trigger, then a return to restriction. The Gifu University study found that restrained eaters also showed positive metabolic outcomes on GLP-1 medications over 12 months, though the pattern differed from external eaters — the medications may reduce the physiological pressure that drives the restriction-and-lapse cycle for some people in this group.
It's also worth knowing that approximately 10% of people don't respond to GLP-1 drugs at all, regardless of eating behavior type. Behavioral pattern helps explain the distribution of outcomes, but biology is never fully predictable. Your doctor's guidance matters here alongside any self-assessment.
What does your honest read of your own pattern say? Not as a diagnosis — just as information worth having.
If You're an Emotional Eater — You're Not Broken, You Just Need More
If You're an Emotional Eater — You're Not Broken, You Just Need More
This is where the GLP-1 conversation most often goes wrong, and it's worth correcting directly.
When someone who predominantly eats in response to emotional states finds that a GLP-1 medication produces limited results, the default framing turns inward: wrong metabolism, wrong body, not disciplined enough. That framing is incorrect, and the researchers who ran this study said so explicitly. Dr. Takehiro Kato of Gifu University was plain: "emotional eating is more strongly influenced by psychological factors — individuals may require additional behavioral or psychological support."
This is a clinical roadmap, not a consolation. The medication is doing what it does. Emotional eating needs a tool designed for the psychological mechanism — and the evidence base for what works is solid and specific.
Cognitive behavioral therapy (CBT) is the most extensively studied intervention for emotional and binge eating. Meta-analyses, including reviews published in the International Journal of Eating Disorders, consistently document significant reductions in emotional eating episodes compared to standard care — many studies finding 50–60% reductions over a full treatment course.
Mindfulness-Based Eating Awareness Training (MB-EAT), developed by Jean Kristeller and studied through NIH-funded trials, builds the pause between emotional state and eating response. Published research shows meaningful improvement in emotional eating scores and reductions in binge eating frequency versus waitlist controls.
Dialectical Behavior Therapy (DBT) and Acceptance and Commitment Therapy (ACT) both build distress tolerance — the capacity to experience a difficult internal state without immediately reaching for a regulating behavior. Both have evidence supporting their use for emotionally-driven eating patterns, with effects comparable to CBT in several head-to-head comparisons.
Here is how these approaches compare in terms of reduction in emotional eating frequency, based on published trials and systematic reviews:
"The goal isn't to stop eating for comfort permanently — it's to give yourself more options when discomfort arrives."
The gift in this research is its specificity. If emotional eating is your dominant pattern, you're not a poor candidate for support. You're a candidate for this kind of support — identified, named, and backed by evidence.
What This Means Whether You're on GLP-1 Drugs or Not
What This Means Whether You're on GLP-1 Drugs or Not
The useful takeaway from this research extends well beyond the medication question.
Knowing what actually drives eating past hunger is directional information with or without a prescription. External eaters can work directly with their environment: reducing line-of-sight exposure to hyperpalatable foods at home, building a brief pause between an environmental food cue and an eating decision, recognizing how social contexts amplify appetite beyond physical hunger. These aren't willpower strategies. They're environmental design — matching the intervention to the actual mechanism.
Emotional eaters are sitting on a different kind of useful information. If stress is the primary driver of extra eating in your life, the most productive question isn't "how do I resist food when I'm stressed?" It's "what else does stress regulation look like for me?" And here the home-cook angle is worth sitting with: the act of cooking itself — working with your hands, following a familiar process, tending something on the stove — is a genuine regulation practice for many people. The kitchen can be a place of creative engagement and settling rather than a site of restriction.
Given how widely GLP-1 drugs have entered everyday life, the behavioral research this Japanese study represents matters at scale. A 2024 KFF Health Tracking Poll found the following among U.S. adults:
Before starting or adjusting GLP-1 treatment, this research gives you something concrete to bring to your doctor: What's your dominant eating behavior pattern, and what behavioral support might make sense alongside the medication? If emotional eating is significant, is a referral to a behavioral health professional or a registered dietitian with eating behavior training worth exploring? What does a realistic 12-month picture look like given your behavioral profile — and what counts as progress along the way?
The drug doesn't do all of this alone. No single tool does. But starting with an honest read of your own eating pattern — the real driver, not just the surface behavior — gives everything else better direction.
What would it feel like to approach that question with genuine curiosity rather than judgment? That shift — from "what's wrong with me?" to "what does my pattern actually tell me?" — might be the most useful thing this research has to offer.
